Thus, it is possible here that the high levels of NGAL detected in vivo (serum) and in vitro (culture media) are related to specific malignant B cell clones sensitive to the CLL microenvironment. The gene discussed is LCN2; the disease is B-cell chronic lymphocytic leukemia.